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It is common for clinicians to implant medical devices, such as permanent pacemakers 
and implantable defibrillators, for cardiac diseases. These medical devices require follow-
up care at regular intervals to ensure proper device function and optimal outcomes.  
Currently, many individuals without insurance or financial resources lack access to 
recommended follow-up care after implantation of a cardiac device.  The purpose of this 
project was to determine the number of individuals who have had a medical device 
implanted without insurance coverage over a 3-year period, and then to establish a clinic 
that provides this service.  The standard of care and operating procedure for the 
pacemaker clinic was established using evidence-based guidelines from the Heart 
Rhythm Society and the American Heart Association.  Complexity science was the 
theoretical model used to guide this project’s design and implementation.  This quality 
improvement initiative was non-experimental, descriptive, and quantitative.  Data were 
extracted from the ICD Registry and United States Census Bureau to determine the 
number of residents, insurance status, and number of implants over a 3-year period.  
These data were used to estimate the number of individuals with devices.  The data 
revealed that 40 individuals with low power cardiac devices and 15 individuals with high 
power devices lacked access to care.  The model developed estimates a growth rate of 7 
to 10% annually.  The pacemaker clinic will provide access to over 70 individuals 
lacking care for their pacemakers, thereby resulting in improved healthcare outcomes, 
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Section 1: The Pacemaker Clinic   
Introduction  
Since the 1950s, use of cardiac implantable electronic devices (CIEDs) has gained 
acceptance in the cardiology discipline as routine therapy. CIEDs are the standard of care 
for many cardiac diseases, including sick sinus syndrome and advanced atrial-nodal heart 
block, as well the standard of care as primary or secondary prevention for sudden cardiac 
death (Modi, Krahn, & Yee, 2011). Technology has advanced rapidly over the past 20 
years, allowing for dramatic reductions in mortality and morbidity for individuals with 
chronic cardiac conditions; technology evolved to include defibrillators for the treatment 
and prevention of sudden cardiac death (Crozier & Smith, 2012).  Cardiac 
resynchronization provided hope and extended the lives of countless individuals with 
systolic heart failure and other cardiac pacing problems (Modi et al., 2011).  
The increased use of CIEDs decreased hospital readmissions for heart failure, thus 
providing a financial incentive for their adoption (Noyes et al., 2013).  This advanced 
therapy has helped control health care cost and promote population health.  In addition, 
technological advances in the microprocessor industry resulted in cardiac devices with 
expanded memory, giving clinicians the information they need to improve patient care.   
 Expenditures for hospital implantable medical devices increased from $16.1 
billion in 2004 to $19.8 billion in 2009 (U.S. Government Accountability Office, 2012). 
The implantable device market is growing at a rate comparable to Medicare and 
represents a significant portion of total Medicare expenditures (U.S. Government 
Accountability Office, 2012). The government payer, the Centers for Medicare, and 






monitoring reduces the number of unnecessary hospital admissions (Abraham & Hayes, 
2003).   
Problem Statement    
 The standard of care requires regular monitoring of CIEDs with in-office 
programming or remote follow-up at regular intervals, as recommended by the Heart 
Rhythm Society (Tracy et al., 2012; Wilkoff et al., 2008). However, in some locations, 
including the area in which this project was conducted, cardiology practices only provide 
care for individuals who can pay or have insurance coverage (J. Wesco, personal 
communication, March 23, 2014). This policy creates a lack of critical access to care. 
Many individuals who received CIEDs urgently through the emergency room or who lost 
insurance coverage after implantation cannot obtain the recommended follow-up care, 
which often leads to severe complications (Ramsdale & Rao, 2012).  
 Individuals with high-voltage devices are at greater risk of experiencing 
complications from inappropriate shocks from their device, thereby raising mortality 
rates by up to 30% (van Rees et al., 2011). The exact cause of the increase in mortality is 
not fully understood, but inappropriate events, such as receiving an unnecessary shock, 
occur more frequently when follow-up care is lacking (Kleemann et al., 2012). 
Complications related to CIEDs are largely avoidable with proper follow-up and care 
(Kleemann et al., 2012).  
 The Heart Rhythm Society recommends regular follow-up for individuals who 
have an implantable device (Wilkoff et al., 2008). Most recipients of a pacemaker should 
have the device interrogated (the process of acquiring data from the device with 






single-chamber, dual-chamber, or bi-ventricular devices, the recommendation for follow-
up care is every 3 months (Wilkoff et al., 2008). Face-to-face follow-up is essential to the 
overall well-being of individuals with implantable devices (Malm & Sandgren, 2014). 
 Gaps in specialized follow-up care are caused by a lack of financial resources 
allocated to individuals with implantable devices who lack private insurance or 
government aid (J. Wesco, personal communication, March 23, 2014). All of the 
cardiology services in the Kansas City metropolitan area are subsidiaries of hospital-
based organizations. This organizational structure allows cardiology practices to function 
in a manner similar to a for-profit corporation, resulting in limited access to individuals 
who do not have the ability to pay for their care via third-party or direct reimbursement 
(J. Wesco, personal communication, March 23, 2014). 
 If an individual receives a CIED on an emergent basis, lacks insurance coverage, 
or moves into the area with an implantable device, there is no place to obtain needed 
follow-up care other than the emergency department (ED). This method is inefficient and 
prevents continuity of care. As a result, patients have poor outcomes. 
Project Objectives    
 The primary goal of the pacemaker clinic at the Health Partnership Clinic is to 
provide care for all individuals with a CIED, regardless of their ability to pay. The goal of 
this project was to identify individuals with devices nearing elective replacement 
intervals before the device exhibits end-of-life behavior. Devices nearing the end of their 
useable life can trigger symptoms consistent with pre-implantation behavior, including 
syncope, chest pain, or in the case of pacemaker-dependent individuals, sudden cardiac 






Significance/Relevance to Practice   
 This change project originated in the ED of a local hospital after several 
encounters with patients (a) who had pacemakers with preventable complications due to 
lack of routine follow-up and (b) who lacked financial means or insurance coverage.  In 
other cases, individuals received a CIED when they presented for urgent care or they 
received a device but did not receive follow-up care due to financial reasons. 
The quality improvement plan for a pacemaker clinic was conceived after 
conversations with the chief executive officer of the Health Partnership Clinic (HPC). 
The HPC is a local clinic that provides services to individuals who have limited or no 
ability to pay for services, or who are on Medicaid, which local providers will not accept 
for payment.  Without sharing patient details that would have compromised 
confidentiality, we determined that the HPC had some patients with CIEDs who were 
receiving only primary care. They were not receiving follow-up care for their cardiac 
needs. Therefore, we decided to assess the need for an extension of services at the HPC 
that would include a CIED clinic. 
Project Question  
Evidence-Based Significance of the Project  
Two models were used in this project: the evidence-based practice model (EBPM) 
and the Iowa model. The EBPM is a tool for organizing a change project (Gawlinski & 
Rutledge, 2008). The Iowa model provides a structured process that assists the project 
manager throughout the project (Schaffer, Sandau, & Diedrick, 2013). The Iowa model 
incorporates feedback into the evolution of the project and allows for adaptation of ideas 






technical subject, CIEDs, which present complex concepts that are difficult to relate to 
patient care, even for cardiac specialists unless they have expertise in electrophysiology 
(Schaffer et al., 2013). Both models were used to guide all phases of the project, 
including decision points. 
Implications for Social Change in Practice   
Initially, it was estimated that 10–20 individuals would not have insurance or the 
financial means to pay for care needed at a pacemaker clinic. Less than 20 people would 
be a small number for a full-time clinic. However, initial data revealed a substantial need 
in the geographic area for a pacemaker clinic that served individuals with no alternative 
for care. 
The establishment of a pacemaker clinic designed to serve a vulnerable 
population was expected to reduce a gap in care and decrease a significant health 
disparity that exists due to financial reasons. By creating this change project and 
instituting the Heart Rhythm Society’s standards for care of CIEDs, individuals would 
have access to a critical component of care that was currently unavailable (Lampert et al., 
2010).  A continuous quality improvement plan was implemented to ensure that quality 
care, as measured by the recognized standards, was provided. The priority was to provide 
safe care and to improve outcomes. 
Definitions of Terms   
 Cardiac implantable electronic device (CIED): An electronic device that is self-






 Cardiac resynchronization device: A CIED that provides pacing therapy to the 
right and left ventricles, either simultaneously or with offset timing, to treat electrical and 
mechanical synchrony in the heart (Ellenbogen & Wood, 2008). 
Device interrogation: A process that uses telemetry to retrieve programmed 
parameters and data stored in the memory of the device. A dedicated programmer or a 
remote server may obtain data (Ellenbogen & Wood, 2008). 
 Device programming: A non-invasive, stable, reversible change in some of the 
operating parameters that enable the provider to select settings to assess and optimize the 
system performance and longevity of the CIED (Hays & Friedman, 2008).  
 Heart failure with preserved ejection fraction: A state of cardiac failure in which 
the systolic function is normal or above normal (Hays & Friedman, 2008). 
Implantable loop recorder (ILR): A device that stores recordings of the heart 
rhythm and data derived from the cardiac rhythm in memory (Ellenbogen & Wood, 
2008). 
Internal cardiovertor defibrillator: A device that provides therapy, such as high-
rate pacing or high-energy shock, to either chamber of the heart (Ellenbogen & Wood, 
2008). 
Pacemaker: A device that provides sensing, pacing, and a response to either 
sensing or pacing to the atrium, right ventricle, or left ventricle of the heart (Ellenbogen 
& Wood, 2008). 
 Programmer: A device designed to receive telemetry from a family of devices 
made by a specific manufacturer of the CIED. The programmer allows the clinician to 






 Remote follow-up transmitter: A device that transmits information stored in the 
CIED to a remote server to which a clinician has electronic access, thereby allowing the 
clinician to assess device settings and diagnostics (Ellenbogen & Wood, 2008). 
Assumptions and Limitations  
Assumptions   
It was assumed that data collected from the public domain, the United States 
Census Bureau, was accurate.  It was necessary to use data in the public domain for this 
quality improvement project.  Generalizations were assumed based upon this data, as 
specific implant data was unavailable.  
Limitations  
A limitation of the data collected for this quality improvement project was that all 
individuals were identified with data available in the public domain; this data may 
underestimate the need. Some individuals cared for by the HPC are undocumented 
immigrants and they may not have been represented in the census data.    
There was no inherent bias in this project. The project was implemented without 
the influence of individual device companies, thus there was no commercial influence. Or 









Section 2: Review of Scholarly Evidence    
Introduction 
 The past decade has seen advances in therapies for individuals with cardiac 
disease, especially for heart failure and management of arrhythmias.  This review of the 
literature will focus on the current treatment of heart failure and arrhythmias using 
CIEDs.  The indications for use and postoperative management of the devices will be the 
focus of this review. 
Literature Search Strategy 
The literature search was conducted using a combined CINAHAL Plus with Full 
Text and MEDLINE with Full Text.  In addition, the Cochrane Database of Systematic 
Reviews was used for meta-analysis.  Keywords included: pacemakers, internal 
defibrillators, cardiac resynchronization, follow-up, remote, in-clinic, and complications.  
This initial search resulted in 3,458 studies. Next, the query was narrowed to the previous 
15 years, which left 881 studies.  This total was narrowed to studies most relevant, 
resulting in 103 articles. Thirty eight studies were most relevant to this quality 
improvement project. 
General Review of Literature    
 CIEDs have been around since the 1950s; they are considered the standard of care 
for many cardiac diseases (Modi et al., 2011). Technology has improved considerably in 
the last two decades and dramatically reduced mortality and morbidity for individuals 
with chronic conditions (Crozier & Smith, 2012). From the early pacemakers to the new 
defibrillators, CIEDs are used to treat and prevent sudden cardiac death. For example, 






failure (Modi et al., 2011).  Some CIEDs provide several kinds of therapy: bradycardia 
support, ventricular arrhythmia therapy, heart failure monitoring, arrhythmia monitoring, 
and heart failure therapy—all in a single device (Wilkoff et al., 2008). 
 Expenditures for hospital implantable medical devices, by the Centers for 
Medicare and Medicaid Services (CMS) and private insurers, increased substantially in 
recent years, from $16.1 billion in 2004 to $19.8 billion in 2009 (U.S. Government 
Accountability Office, 2012). These expenditures represent a growth rate in excess of 
20%.  
 After the initial implantation of a CIED, significant follow-up is required to 
prevent complications and maximize device function. Udo et al. (2011) conducted a 
multicenter randomized cohort study from 2003 to 2007 with 1,517 patients who had 
received a CIED. They found that 12.4% of these patients developed complications over 
the first 2 months. Thereafter, 9.2% of patients developed long-term complications (Udo 
et al., 2012). The researchers were unable to predict who would develop complications. 
 Follow-up is critical to the proper functioning of a device.  However, there 
remains considerable debate in the cardiology community about the frequency and type 
of follow-up care required for patients with CIEDs (Van Eck et al., 2008). Van Eck et al. 
(2008) conducted secondary data analysis to determine the frequency of visits, the 
parameters measured during the follow-up, and the training of the personnel involved in 
this care. They found that (a) non-physicians perform the majority of these checks and (b) 
that crucial parameters were monitored, and appropriate parameter changes made to 






 The result of pacemaker complications can be severe and dramatic. Ellenbogen, 
Wood, and Shephard (2002) found one potential complication. Delayed perforation of the 
chamber receiving the pacemaker lead may occur days to weeks after the initial 
implantation. If left untreated this can result in the death of the patient. However, this 
condition is readily assessable with a routine follow-up and examination by a provider. 
Specific Review of Literature   
 The specific review will focus on the management of individuals postoperatively 
after implantation of a CIED.  The device specific requirements will be addressed 
including pacemakers, defibrillators, and cardiac resynchronization devices.  The 
indications and required care of these devices along with the training required to provide 
this care will be addressed. 
 Other than patients and their families, who are primary stakeholders in the success 
of CIEDs, three organizations are major stakeholders. These organizations monitor and 
govern the usage of CIEDs: the American College of Cardiology, the American Heart 
Association, and the Heart Rhythm Society. These organizations work with the Food and 
Drug Administration and the CMS to approve and monitor devices and set payment 
parameters. Members of these organizations conduct research studies and the results of 
the studies are published in peer-reviewed journals. Professionals from many disciplines 
work together to provide guidelines for device usage that help clinicians care for cardiac 
patients needing CIEDs. 
General Follow-Up Considerations  
 All CIEDs, regardless of the type, have follow-up requirements. The four 






disease-related considerations, and communication-related considerations (Wilkoff et al., 
2008).  
Patient-related issues. The primary objective of CIED follow-up is to optimize 
individuals’ quality of life and to minimize the impact the device has on individuals’ 
daily life activities. This goal is accomplished ensuring the system functions to meet each 
individual’s needs. Time spent during the follow-up interaction also gives the clinician an 
opportunity to identify other health issues that may need attention. 
Device-related issues. This goal includes the documentation of device function. 
When device function is abnormal, clinicians take corrective action. Monitoring the 
device is documented throughout the lifespan and planning for device succession occurs 
before failure of the device.  
Disease-related issues. Diagnostics collected by the device provide insight into 
disease progression and the specifics needed to provide optimal care. Device follow-up 
sessions provide the clinician with access to this information. Clinicians can access and 
share this information with multidisciplinary team members.  
Communication issues. CIEDs require a line of communication remain in place 
between manufacturer, clinician, and patient. Issues might arise with specific models 
from the device manufacturer, necessitating the sharing of information. Patients need 
access to their clinician, clinicians need access to the manufacturer, and the manufacturer 
needs access to patients via clinicians. 
Indications for Implantation   
 The American College of Cardiology, American Heart Association, and the Heart 






evidence class (Epstein et al., 2013): Class I conditions are those for which pacing 
treatment is definitely beneficial and necessary to prolong life. Examples of Class I 
conditions include heart blockage, asystole, or bradycardia that is hemodynamically 
compromising to an individual. Class II conditions are those in which pacing may be 
indicated, but there is some conflicting evidence or divergence of opinion. Class III 
conditions are those for which pacing may or may not be useful and may be potentially 
harmful. 
Low-Powered CIED   
Indications. Indications for low-powered devices or pacemakers include rhythm-
related reasons, high-degree atria-nodal blockage, and symptomology. Symptoms related 
to heart rate include dizziness, lightheadedness, syncope, fatigue, poor exercise tolerance, 
and chest pain (Modi et al., 2011). Pacemakers may be dual-chamber devices with a lead 
into the right atrium and left ventricle, or single-chamber pacemakers with one lead into 
either the atrium or ventricle (Modi et al., 2011). 
Follow-up considerations. Low-powered devices require follow-up at regular 
intervals. The first in-person follow-up should be within 72 hours of device implantation 
(Wilkoff et al., 2008). Parameters to be assessed include battery status, lead performance, 
pacing and sensing thresholds, and the diagnostics of these primary indicators. After this 
initial contact, follow-up should occur between 2 and 12 weeks. After this contact, 
follow-up can be every 3 months if remote follow-up is activated. In-clinic follow-up 
should occur no less than every 12 months (Wilkoff et al., 2008). As device longevity 
approaches elective replacement levels, follow-up is necessary at monthly intervals until 






High-Powered CIED  
The role of the implantable defibrillator has increased over the last 20 years. 
Initially, these devices were implanted for survivors of two episodes of sudden cardiac 
death (Greenberg et al., 2004). During the 1990s, the indications were expanded to 
include primary prevention of sudden cardiac death (Greenberg et al., 2004). Large 
multicenter studies such as MADIT and MADIT II demonstrated superior survival rates 
compared to traditional medication therapy (Greenberg et al., 2004). Devices have 
become smaller, more efficient, and safer over the years. 
Indications. Indications for high-voltage devices are either primary prevention 
based upon heart function and risk factors or secondary prevention for sudden cardiac 
death. The major risk factor for sudden death is structural heart disease, either from 
coronary artery disease (ischemic) or other forms of cardiomyopathy not related to 
coronary artery disease (non-ischemic) (Desai, Fang, Maisel, & Baughman, 2004). 
Researchers demonstrated a significant reduction in mortality from the use of ICDs in 
both forms of structural heart disease (Desai et al., 2004; Greenberg et al., 2004). 
Follow-up considerations. High-powered device follow-up requirements are 
similar to follow-up requirements to low-powered devices, with additional requirements 
unique to these devices. Clinicians monitor battery status, lead performance, pacing and 
sensing thresholds, high-voltage capacitor functioning, and charge time. The high-voltage 
functioning feature is the most important function of a high-voltage device. 
Cardiac Resynchronization CIED  
 As the burden of heart failure has increased for individuals and society, new 






One such therapy is cardiac resynchronization therapy (CRT). The CRT CIED provides 
electrical stimulation in multiple areas of the ventricle for individuals experiencing 
mechanical problems; such problems often lead to severe complications (Ramsdale & 
Rao, 2012).  
Indications. The indications for CRT are heart failure, New York III or IV class, 
systolic dysfunction, and prolonged ventricular depolarization (QRS greater than 140ms; 
Burkhardt & Wilkoff, 2007). These indications were revised over the past several years 
and have become more restrictive in response to the ongoing debate over the long-term 
benefit for some populations.  
Follow-up considerations. In addition to the follow-up needed for both low- and 
high-powered CIEDs, CRT CIEDs are used to treat heart failure. These devices have 
additional diagnostics capabilities that help clinicians assess fluid volume. This CRT 
CIEDs feature requires nearly constant monitoring. To address the need for nearly 
constant monitoring, remote monitoring is active at all times in the devices; outside of the 
hospital, the device maintains communication with home units that have Internet access. 
An alert triggered in the device by a cardiac event is sent to a database and then 
forwarded to the individual’s clinician for review. 
Multidisciplinary Relationships  
Given the complexity of CIEDs, it may be necessary to obtain technical support 
for an individual’s care (Hayes, Juknavorian, & Maloney, 2001). Industry allied 
professionals are individuals with industry training that may be certified by the 
International Board of Heart Rhythm Examiners. The Heart Rhythm Society also 






2001). It is important to maintain awareness of the conflict of interest that is inherent 
when a device manufacturer employs a care provider. Decisions regarding patient care 
should occur in the absence of conflicts of interest. While technical advice can be sought, 
healthcare providers tasked with caring for the patient best make decisions that affect 
patients. 
Adverse Events  
For patients who receive a CIED, the standard of care requires regular monitoring 
of these devices with in-office programming or remote follow-up at regular intervals, as 
recommend by the Heart Rhythm Society (Tracy et al., 2012; Wilkoff et al., 2008). 
Remote Follow-Up  
 One of the most significant changes with regard to monitoring of CIEDs is remote 
follow-up using the Internet. This change occurred rapidly. While programming or 
changing settings is unavailable via the telephone or Internet, almost every piece of 
information stored in the device can be transmitted into a database accessible by 
clinicians in real time. It is important for patients with a CIED to be aware of negative 
information related to their CIED. In the case of individuals with atrial fibrillation at risk 
for stroke who cannot be anti-coagulated, remote follow-up can be used to detect this 
rhythm disorder and notify the healthcare provider about this abnormality (Gimbel, 
2012). When an individual has a normal heart rhythm, there are no transmissions, thus 
indicating no need for intervention. Remote follow-up used in conjunction with 
traditional in-office follow-up also offers improved productivity for clinics that adopt this 
method (Cronin et al., 2012). More importantly, outcomes improve for patients who have 






Theoretical Framework   
The way healthcare is provided in the United States works well for a few 
individuals, however there remain a substantial number of people without insurance or 
the ability to pay for healthcare. Since early 2014, the healthcare system has not been 
functioning as intended. As such, theory based upon a nonlinear worldview is best for 
research into a phenomenon as complex as the healthcare system. Traditional linear 
thinking, in which the input equals the output or the size of the input is equal to the size 
of the output, must be replaced with the understanding that small changes can create great 
change. Complexity science (CS) describes phenomena as they are rather than how they 
should be. 
Simple agents, or initiatives, that are basic units following simple rules can 
generate complex structures (Paley, 2007). The relationship between these simple agents 
defines CS. Paley (2007) used CS and the understanding of complex adaptive systems 
(CASs) to determine why a cardiac rehabilitation unit was not receiving referrals. Paley 
(2009) identified many individual elements that were not considered complex issues but 
that, in aggregate, formed a bottleneck for referrals to this service. Using complexity 
analysis, Paley developed a new system that satisfied the needs of all stakeholders.  
For a project that is multidisciplinary, using facilities from primary to tertiary 
care, and crossing many specialty practices, the Iowa model is not sufficient as a stand-
alone mode. It serves well as the model for data collection, however a more 
comprehensive theory must be used in conjunction to capture the complete theme of the 






meaningful change in organizations (Hast, DiGioia, Thompson, & Wolf, 2013). It is well 
suited for the development of a pacemaker clinic. 
Definition of Complexity Science  
CS is neither a single theory nor exclusively a nursing theory; it is an 
interdisciplinary field recognizing multiple theoretical frameworks (Zimmerman, 
Lindberg, & Plsek, 2001). Lindberg, Nash, and Lindberg (2008) defined CS as 
“examining systems comprised of multiple and diverse interacting agents and seeking to 
uncover the principles and dynamics that affect how such systems evolve and maintain 
order” (p. 78). Zimmerman et al. (2001) stated that CS gives “a description of the 
complex phenomena demonstrated in systems characterized by nonlinear components, 
emergent phenomena, continuous and discontinuous change, and unpredictable 
outcomes” (p. 112).  
Concepts of Complexity Science  
CS recognizes that individuals, businesses, hospitals, and all systems are CASs. 
The word complex implies diversity and a great number of connections between wide 
varieties of elements; adaptive refers to the capacity to alter or change and the ability to 
learn from experience; and system refers to a set of connected or interdependent things 
(Zimmerman et al., 2001). CASs have many interconnected, interdependent, adaptive, 
and diverse elements, each of which may be a CAS (Lindberg et al., 2008). Diversity is 
essential for CASs because diversity allows for adaptation when confronted with a 
challenge. The interdependent nature of CASs is evidence that an individual cannot 






The eight major properties of CASs include diversity, self-organization, 
embeddedness, distributive control, nonlinear dynamics, adaptable elements, emergence, 
and the coexistence of order and disorder (Lindberg et al., 2008). A definition of each 
property is provided below. 
 Diversity. CASs are composed of heterogeneous parts in the system. Diverse 
elements enable the system to function at a higher level and outperform homogeneous 
groups. 
 Self-organization. CASs are subject to influence from many forces within and 
outside of the CAS that may create novel patterns, structures, and processes. Simply put, 
there is no such thing as a static CAS. 
 Embeddedness. Each agent is itself a CAS, as well as a part of all CASs that, in 
turn, make up a larger CAS. There is no such thing as isolation in CS and there is no 
insignificant CASs. Every individual may have great, little, or no impact on the larger 
CAS. 
 Distributive control. The concept of individual control does not exist within a 
CAS. Many agents formally and informally share control. Diversity is at the center of 
control in a CAS.  
 Non linear dynamics. The effect of a change agent in a CAS is difficult to 
predict. This unpredictability is due to the non-linear behavior of a CAS. Small changes 
may have large effects in a CAS, but can have proportional effects or no change at all. 







 Adaptable elements. For a CAS to survive, it must be adaptable and have 
elements within the global CAS that are able to adapt. Biological species have the ability 
to modify themselves to survive the evolutionary process. CASs possess the ability to 
survive as organizations. 
 Emergence. CASs are not static organizations creating new and unexpected 
structures, patterns, or processes within the overall system. Emergents can take on a life 
of their own and create their own rules. 
 The coexistence of order and disorder. It is not essential for a CAS to have 
order. Instead, a CAS can thrive with or without order because the normal state of a CAS 
includes order and disorder. 
Complexity Science and Nursing   
The embedded principles of CS are evident in nursing practice. A schism exists, 
however, between practice and nursing theory. Current nursing theory has been 
predominantly derived from a linear worldview rather than from a dynamic, unitary 
worldview. Lindberg et al. (2008) suggested linear theories are detrimental to nursing 
education and negatively influence all aspects of nursing. CS provides an alternative to 
linear thinking and theorizing. It is a complementary perspective to facilitate describing, 
understanding, and using nursing theories that are compatible with nursing concepts and 
constructs (Lindberg et al., 2008). Using the concepts of CS to guide nursing research is 
the next logical step. 
Complexity science provides a comprehensive framework to understand and 






parts, is dynamic and in a constant state of change.  This framework defined and captured 







Section 3: Methodology   
Introduction 
This study was designed to provide the necessary information to quantify the 
scope of the problem facing individuals lacking access to care who have an implantable 
cardiac device.  The methods used to document the need will be covered in detail. Data  
from the Centers for Medicaid and Medicare Services, the United States Census Bureau, 
and the Health Partnership Clinic were used to develop a historical and predictive model 
to predict need. 
Approach 
Project Design    
This quality improvement project used a non-experimental, descriptive, 
quantitative research design.  It involved the secondary analysis of archival data, data 
provided by the Health Partnership clinic without patient identifiers or proprietary data. 
Population and Sampling    
U.S. Census Bureau data included the number of individuals residing in the 
geographical area, individuals who lost access to health insurance coverage in any given 
year, and the total number of device implants as reported to the Centers for Medicaid and 
Medicare.  Descriptive analysis was used to determine the number of patients who had 
implantable devices but lacked access to care.  
Two types of data were collected: the actual number of implantable devices and 
the insurance status of residents in the area. No patient identifiers were associated with 
this data. Inclusion criteria were as follows: CIED implants in Johnson County, Kansas, 






obtained from U.S. Census Bureau data and used as a baseline to estimate the number of 
uninsured with an implantable device.  
Methods for Safeguarding Human Subjects   
 Data were obtained after approval from the Walden University Institutional 
Review Board (12-01-14-0307415). Because no patient identifiers were included in the 
data, there was no risk associated with unauthorized use of the data or violations of 
confidentiality. No human subjects were involved in the collection of this data. 
Ethical Issues 
 The concept of autonomy is one of the guiding principles of ethical care 
(American Nurses Association, 2001). Autonomy allows all competent individuals to 
refuse any or all treatment provided. Refusal of treatment can be a difficult situation 
when the device is implanted improperly and cannot be easily removed from the 
individual’s body (Kobza & Erne, 2007). Cultural and religious beliefs may influence 
individuals’ healthcare decisions. Ethical issues are relevant for individuals with 
implantable devices and these devices often provide therapy needed to live (Kobza & 
Erne, 2007). For some individuals, withdrawal of therapy results in immediate death. 
Withdrawal of basic support is controversial and can be considered euthanasia. The 
individual ultimately controls his or her own destiny and others should respect the 
autonomy of this right.  
 At end of life, a patient may wish to terminate therapies provided by the device. 
When this situation occurs, the provider must have a thorough discussion with the patient 







 There are no human subjects in this quality improvement project.  There are no 
patient identifiers associated with any data collection.  The archival data collected was 
anonymous and was stored on the investigators computer.  The raw data will be 
destroyed at the conclusion and publication of this project.  The project was undertaken at 
a clinical site and no incentives were associated with this project. 
Data Analysis Strategies   
 The total numbers of CIEDs were tallied along with the likely number of 
individuals with CIEDs who might lack access to care, based upon implant numbers from 
the ICD registry. Patient-specific indicators including age and gender were obtained. The 
analyses included comparisons of means and the total number of identified individuals.  
Project Evaluation Plan   
Evaluation Strategies   
The first step in this study was to review the literature on an ongoing basis to 
compare actual performance of the clinic with evidence-based studies and consensus 
practice. This information was used to ensure that, in the rapidly changing environment 
of clinical care, the clinic will follow and maintain best practices. A systematic quality-
monitoring plan was created as an addition to the ongoing quality program in place at the 
HPC to monitor a random sample of patient encounters to ensure that standards are 
followed. 
New Practice Guidelines   
Guidelines for practice fall into three categories: pacemakers, defibrillators, and 
CRT devices. A set of protocols was established for each implantable device. The 






technical and communication limitations some individuals face. Patient checks are 
scheduled every 90 days for all types of devices, with remote checks being allowed for 3 
of 4 annual checks for pacemakers. For high-voltage devices, remote checks can be used 
biannually, with one in-clinic check performed every 6 months. 
For individuals on antiarrhythmic medication, more frequent follow-up may be 
recommended on an individual basis (Wong, Yu, & Holbrook, 2010). For individuals 
receiving high-voltage therapy, consultation with a local electrophysiologist or 
cardiologist specializing in the care of patients with these devices is needed to ensure 
optimal medical management (Lampert et al., 2010). 
For clinic patients taking antiarrhythmic medication, an alert was built into the 
electronic record. This alert will make primary care providers and staff aware of the 
potential serious drug interactions that some medications, especially antibiotics, might 
have on the conduction system of the heart when an ADD is being used. 
New Standards of Care at the HPC   
Patients visiting the HPC for medical device follow-up can expect to receive care 
provided at traditional pacemaker clinics. The Heart Rhythm Society is the organization 
that guides private and public payers’ treatment of heart rhythm disorders. This 
organization works closely with the U.S. Food and Drug Administration and the suppliers 
of medical devices to monitor and report potential adverse outcomes related to devices 
already implanted. The Heart Rhythm Society sets the care and follow-up standards for 
care of CIEDs. 
The Heart Rhythm Society recognized the role of the non-physician provider in 






of care (Gura et al., 2003). The core knowledge and skills are detailed in this position 
statement including: Core Knowledge, Core Standards and Elements, Rhythm 
Management, and Follow-up (Gura et al., 2003). The International Board of Heart 
Rhythm Examiners (IBHRE) offers certification as a Cardiac Electronic Device 
Specialist (CEDS) to eligible candidates to document their knowledge (Gura et al., 2003). 
The staff performing follow-up interrogations at the Health Partnership Clinic will be 
required to have this CEDS certification. 
Project Strengths and Limitations 
Analysis of Self 
The role assumed by the project manager/student was comprehensive: scholar, 
manager, practitioner, administrative and cheerleader.  The most significant contribution 
made was to create an atmosphere where the need for this service was appreciated and 
with resulting social change.  The easy part was to provide the service.  The development 
of the project required patience and extensive management of resources.  It was very 
gratifying to make multiple presentations to the board of directors with a positive 
outcome. 
Summary 
 This project, when fully implemented will provide evidence base care to a 
vulnerable population with cardiac devices.  This specialized care is not available to 
residents in the geographical area at this time.  Thus, a critical need will be filled as a 







Section 4: Findings, Discussion and Implications  
Findings  
 Johnson County, Kansas, experienced a decline in the population from 2011 to 
2012; however, the population grew in 2013 to 417,507 individulals (United States 
Census Bureau, 2014). Given this variability, the poplulation of  adults over the age of 18 
for 2001–2013 was used for this study: 407,669 (United States Census Bureau, 2014).  
Table 1 
Number of Adults in Johnson County, Kansas by Age 
Year 18– 65  
years of age 
Over 65  
years of age 
Total  
population 
2011 344,936 59,743 404,679 
2012 341,501 59,322 400,823 
2013 350,577 66,930 417,507 
2014 345,671 61,998 407,669 
  
Number of CIED Implants in Johnson County, Kansas  
 The number of total implants was obtained from St. Jude Medical’s marketing 
department (C. Peltz, personal communication, December 08, 2014). This information is 
available via request and is acquired from industry data and publically reported financial 
 reports. The total number of low power implants averaged 728 per year for the years 
2011 to 2013. The total number of high power implants for the same time period was 
718, averaging 239 per year. There was a slight contraction in implants during this time 








Number of Low and High Powered Medical Device Implants for Johnson County, Kansas 
Year Number of Low Voltage 
Implants 
Number of High Voltage 
Implants 
2011 732 263 
2012 762 253 
2013 679 202 
Total 2,183 718 
 
Number of Uninsured Johnson County Residents  
 The number of  uninsured residents in Johnson County remained steady during 
the years 2011 to 2013 and averaged 21,730 uninsured adults between the ages of 18 and 
65 (United States Census Bureau, 2014). Very few of the individuals over 65 had 
minimal insurance through Medicare. What is not known is the number of individuals 
lacking Medicare Part D and the number unable to afford physician visits. The researcher 
assumed that they were represented in this number with an average of 85 individuals 
annually. 
Table 3 
Number of Uninsured Residents in Johnson County  
Year Between 18 – 65 Years of 
Age 
Over 65 Years of Age  
2011 22,225 175 
2012 21,607 39 
2013 21,358 42 








Implant Demographics  
 The number of CIED implants increases significantly with age. The exact number 
of non-Medicare implants is unavailable in the public domain and local hospitals consider 
this information proprietary and will not disclose the exact numbers. The largest study 
that tracks medical device implants by age is the ICD registry sponsored by the Heart 
Rhythm Society and the American College of Cardiology Foundation (Kremers et al., 
2013). This registry has over 850,000 participants and represents the most comprehensive 
database for CIED implants in the United States (Kremers et al., 2013).  This database 
represents hospitals’ voluntary reporting, which has the possibility to not accurately 
represent the data.  The data from this registry demonstrated that 35% of CIED implants 
occur in the under 65 age group, thus this number was used given the assumption that 
individuals in the under 65 age group receive CIED implants.  
Table 4 
CIED Implants per Thousand of Total Population 
Year Low Voltage High Voltage  
2011 1.809 0.650 
2012 1.901 0.631 
2013 1.626 0.484 
Average 1.779 0.588 
 
Estimated Number of Noninsured Individuals Receiving CIEDs  
 Using the assumption of the ICD registry, that 35% of CIED implants occur in the 
under 65 age group and no hospital in the county provides pediatric services, the number 
of implants per 1000 individuals was applied to the 18 to 65 population with the 






then applied to the uninsured group to estimate the total number of implants for both low- 
and high-voltage devices. 
Table 5 
Number of Potential Individuals with CIEDs Lacking Access to Care Over the Past 3 
Years Based Upon 35% for Age 18-65 and 65% Over Age 65 
Year Between ages 18 – 65 years  Over 65 Years of age          
 Low Voltage High Voltage Low Voltage High Voltage 
2011 14 5 <1 <1 
2012 13 5 <1 <1 
2013 13 5 <1 <1 
Total 40 15 <1 <1 
 
 It is estimated that 13 low-voltage implants, along with 5 high-voltage implants, 
occur in the uninsured population annually in Johnson County. The number of implants 
in the over 65-age group is less than one annually. This finding is consistent with 
information provided by the Health Partnership patient database. Given that the average 
life of a CIED is 5 years and the average length of patient relationships at the Health 
Partnership Clinic, it is likely that there are currently 40 individuals with low-power 
devices and 15 individuals with high-power devices lacking recommended care. This 
number is likely to grow as Kansas has elected not to extend Medicaid benefits to this 
group of patients. 
Discussion  
 The total population lacking medical care for their implanted devices in Johnson 
County, Kansas, is substantial. Using the assumptions from the United States Census 






lacking care is a significant and stable size. The recent implementation of the Affordable 
Care Act is not likely to change this need, as Kansas has not expanded Medicaid 
eligibility. 
Implications  
 For individuals lacking access to care with an implantable CIED the ramifications 
can be catastrophic. Seniors complications can and often occur without proper follow up 
care. For local institutions the financial implications can be considerable. With the 
average emergency department visit for a CIED complication costing $12,000, it only 
takes a few preventable complications to have a significant impact (S. Elsey, personal 
communication, December 6, 2014). The availability of care will enhance individuals’ 
lives and provide a place for medical care. This will result in positive social change for 
over 50 residents of Johnson County within the first few months of this clinic’s 
formation. 
Summary and Conclusions 
 There is a definite need for social change in Johnson County Kansas to provide 
access to care to uninsured, undocumented, and individuals without the ability to pay for 
specialty cardiac care.  Many individuals that have implantable cardiac devices cannot 
achieve full health without access to care.  This project identified this need and provided 
a workable solution.  Using skills learned in the terminal degree program for the Doctor 
of Nurse Practice, a program to address this need was successfully developed, funded, 
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The Creation of a Pacemaker Clinic at a Federally Funded Patient Centered Medical 
Home as a Quality Improvement Project 
 Since the 1950s, use of cardiac implantable electronic devices (CIEDs) gained 
acceptance in the cardiology realm as routine therapy. CIEDs are the standard of care for 
many cardiac diseases, including sick sinus syndrome, advanced atrial-nodal heart block, 
and as primary or secondary prevention for sudden cardiac death (Modi et al., 2011). 
Technology has advanced rapidly, allowing for dramatic reductions in mortality and 
morbidity for individuals with chronic cardiac conditions (Crozier & Smith, 2012). From 
the humble pacemaker, technology evolved to include defibrillators for the treatment and 
prevention of sudden cardiac death. 
 Expenditures for hospital implantable medical devices increased from $16.1 
billion in 2004 to $19.8 billion in 2009 (U.S. Government Accountability Office, 2012). 
The implantable device market is growing at a rate comparable for Medicare and 
represents a significant portion of total Medicare expenditures. The government payer, 
the Centers for Medicare and Medicare Services (CMS), benefits when CIEDs are cared 
for after implantation by reducing unnecessary hospital admissions.  
 Cardiac resynchronization has provided hope and extended the lives of countless 
individuals with systolic heart failure and other cardiac pacing problems (Modi et al., 
2011). The increased use of CIEDs also helped decrease readmissions for heart failure, 
thus providing a financial incentive for their adoption (Noyes et al., 2013).  
Project Objectives    
 The goal of the pacemaker clinic at the Health Partnership Clinic is to provide 






change will result in an increased quality of care, as evidenced by complication rates 
consistent with the national average for individuals receiving care in traditional 
pacemaker clinics. The secondary goal of this project was to identify individuals with 
devices nearing elective replacement intervals before the device exhibits end-of-life 
behavior.  
Significance/Relevance to Practice   
 On multiple occasions, individuals present to local Emergency Departments with 
preventable device complications from lack of routine follow-up. In some cases, 
individuals lost their insurance and could no longer afford clinic visits. In other cases, 
individuals receive a CIED when presenting for urgent care, yet do not receive follow-up 
care. The common thread is these individuals are unable to obtain follow-up care, 
primarily due to financial reasons. 
 A pacemaker clinic was conceptualized after conversations with the Chief 
Executive Officer of the Health Partnership Clinic (HPC), a local clinic that provides 
services to individuals with limited or no ability to pay for services, or Medicaid, which 
local providers will not accept for payment. Local practices have limited space for these 
patients to receive care (Health Care Partnership, 2014). Without sharing patient details 
that would have compromised confidentiality, we determined that the Health Care 
Partnership had some patients receiving primary care with CIEDs. These patients were 
not receiving follow up care for their cardiac needs. As such, we decided to assess the 






New Standards of Care at the HPC 
 Patients visiting the HPC for medical device follow-up can expect to receive care 
provided at traditional pacemaker clinics. The Heart Rhythm Society is the organization 
that guides private and public payers’ treatment of heart rhythm disorders. This 
organization works closely with the U.S. Food and Drug Administration and the suppliers 
of medical devices to monitor and report potential adverse outcomes related to devices 
already implanted. The Heart Rhythm Society sets the care and follow-up standards for 
care of CIEDs. 
 The Heart Rhythm Society has recognized the role of the non-physician provider 
in the care of CIEDs and issues a policy statement to detail the qualifications and 
standards of care (Gura et al., 2003). The core knowledge and skills are detailed in this 
position statement including: Core Knowledge, Core Standards and Elements, Rhythm 
Management, and Follow-up (Gura et al., 2003). The International Board of Heart 
Rhythm Examiners (IBHRE) offers certification as a Cardiac Electronic Device 
Specialist (CEDS) to eligible candidates to document their knowledge (Gura et al., 2003). 
The staff performing follow-up interrogations at the Health Partnership Clinic will be 
required to possess this certification. 
Number of CIED Implants in Johnson County Kansas  
 The number of total implants was obtained from industry information from St. 
Jude Medicals marketing department (C. Peltz, personal communication, December 8, 
2014). This information is available to the public via request. The total number of low 
power implants average 728 per year for the years 2011 to 2013 . The total number of 






was a slight contraction in implants during this time period, so the average of the three 
years will be used for this study. 
Number of Uninsured Johnson County Residents  
 The number of residents in Johnson County remained steady during the years 
2011 to 2013 and averaged 21,730 for adults between the ages of 18 to 65 (United States 
Census Bureau, 2014). For individuals over 65 there were very few individuals not 
having minimal insurance through Medicare. What is not known is the number of 
individuals lacking Medicare Part D and not able to afford physician visits. The 
assumption will be made that they are represented in this number with an average on 85 
individuals annually. 
Implant Demographics  
The number of CIED implants increases significantly with age. The exact number of 
Non-Medicare implants is not available in the public domain. Local hospitals consider 
this information proprietary and will not disclose the exact numbers. The largest study 
that tracks medical device implants by age is the ICD registry sponsored by the Heart 
Rhythm society (Kremers et al., 2013). This registry has over 850,000 participants and 
represents the most comprehensive database for CIED implants in the United States 
(Kremers et al., 2013). This registry demonstrated that 35% of CIED implants occur in 
the under 65 age group, thus this number will be used in the assumptions of individuals 
receiving CIED implants in this demographic. 
Estimated Number of Non Insured Individuals Receiving CIEDs  
 Using the assumption of the ICD registry, that 35% of CIED implants occur in the 






of implants per 1000 individuals will be applied to the 18 to 65 population with the 
assumption that 35% of the total implants in the county occurred in this group. This will 
then be applied to the uninsured group to estimate the total number of implants for both 
low and high voltage devices. 
 It is estimated that 13 low voltage implants, along with 5 high voltage implants, 
occur in the uninsured population annually in Johnson County. The number of implants 
in the over 65-age group are less than one annually. This finding is consistent with 
information provided by the Health Partnership demographics. Given that the average life 
of a CIED is 5 years, and the average length of patient relationships at the Health 
Partnership Clinic, it is likely that there are currently 40 individuals with low power 
devices, and 15 high power devices lacking recommended care. This number is likely to 
grow as Kansas has elected not to extend Medicaid benefits to this group of patients. 
Implications  
 For individuals lacking access to care with an implantable CIED the ramifications 
can be catastrophic. Serious complications can and often occur without proper follow-up 
care. Local institutions risk considerable financial implications of providing mandated 
care to the uninsured population. The average emergency department visit for a CIED 
complication costing $12,000 in this area.  It only takes a few preventable complications 
to have a significant impact on local hospitals (S. Elsey, personal communication, 
December 6, 2014).  For individuals, the availability of care will enhance their lives 
physically and provide the emotional security of a medical home. Positive social change 
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